Mergers & Acquisitions Mergers & Acquisitions

Illumina-Grail deal ‘met conditions’ for EU referral, Norway says

By Natalie McNelis
  • 09 Apr 2021 10:40
  • 31 May 2021 05:48
Illumina’s bid to take over cancer-testing company Grail met the conditions for referral to the EU merger regulator, Norway says.
The Norwegian competition authority confirmed to MLex that it had joined the French competition authority's request for the Illumina-Grail deal to be referred to the European Commission (see here). 


To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Natalie McNelis

Senior Correspondent

Natalie McNelis covers mergers for MLex in Brussels. Before joining MLex in 2017, she spent 20 years as an international trade and competition lawyer in law firms including Stibbe and WilmerHale. Natalie has a BA in English from Mount Holyoke College, a JD from Harvard Law School and an LLM in EU law from KU Leuven. She is admitted to the bar in New York.

Discover MLex

Stay on top of global regulatory developments

Latest News